Related Experiment Videos
Decreasing insulin requirements in CAPD patients given intraperitoneal insulin
N Grefberg1, B G Danielson, C Berne
1Department of Internal Medicine, University Hospital, Uppsala, Sweden.
The Journal of Diabetic Complications
|January 1, 1987
Summary
Intraperitoneal insulin administration in diabetic patients undergoing continuous ambulatory peritoneal dialysis (CAPD) significantly reduced insulin needs and improved metabolic control compared to subcutaneous delivery. This suggests a more effective route for managing diabetes in dialysis patients.
Area of Science:
- Nephrology
- Endocrinology
- Metabolic Disorders
Background:
- Diabetic patients undergoing dialysis require careful insulin management.
- Subcutaneous insulin is a common but potentially less effective route in this population.
Purpose of the Study:
- To compare insulin requirements in diabetic patients on dialysis using subcutaneous versus intraperitoneal insulin administration.
- To assess the impact of insulin route on metabolic control in CAPD patients.
Main Methods:
- Retrospective study comparing two groups of dialyzed diabetic patients.
- One group received subcutaneous insulin, the other intraperitoneal insulin.
- Analysis of insulin requirements and metabolic control over time.
Main Results:
- Subcutaneous insulin requirements remained stable in both hemodialysis and CAPD patients.
- CAPD patients receiving intraperitoneal insulin showed a significant decrease in insulin needs.
- Improved metabolic control was observed concurrently with reduced insulin requirements in the intraperitoneal group.
Conclusions:
- Intraperitoneal insulin administration appears advantageous for diabetic patients on CAPD.
- This route may offer improved glycemic management and reduced insulin dosage compared to subcutaneous delivery.